Metraipolis › archive › dc_bf31e7804d0c

SGLT2 inhibitors and diabetic retinopathy progression: evidence from a retrospective cohort study and Mendelian randomization analysis — Europe PMC PMID:42534740

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42534740
DOI
10.3389/fendo.2026.1846454
License (as archived)
solo-consultazione
Archived
2026-10-18T06:21:28.303Z
SHA-256 of the archived text
69410a3afddb5b099bc4f4f97016ca6236e8039340ca901b1ff6e25e4df50fec
Stable URL of this page
https://metraipolis.com/documento/dc_bf31e7804d0c

How to cite

SGLT2 inhibitors and diabetic retinopathy progression: evidence from a retrospective cohort study and Mendelian randomization analysis — Europe PMC PMID:42534740 — Europe PMC (en), https://europepmc.org/article/MED/42534740 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf31e7804d0c (Metraipolis archive dc_bf31e7804d0c, sha256 69410a3afddb5b099bc4f4f97016ca6236e8039340ca901b1ff6e25e4df50fec)
BibTeX
@misc{dcbf31e7804d0c,
  title = {SGLT2 inhibitors and diabetic retinopathy progression: evidence from a retrospective cohort study and Mendelian randomization analysis — Europe PMC PMID:42534740},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42534740},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf31e7804d0c; sha256 69410a3afddb5b099bc4f4f97016ca6236e8039340ca901b1ff6e25e4df50fec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42534740. Agents can read the archived copy with the MCP tool read_document.